Gerresheimer AG (XSWX:GXI) Other Long-Term Liabilities: CHF308 Mil (As of Nov. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:GXI Gerresheimer AG XSWX:GXI
68 GF Score
Price CHF25.84
GF Value CHF90.02
! 6 Warning Signs
View Full Analysis

What is Gerresheimer AG Other Long-Term Liabilities?

Gerresheimer AG XSWX:GXI 68 Other Long-Term Liabilities is CHF308 Mil as of Nov. 2025. GuruFocus rates XSWX:GXI with a GF Score™ of 68/100 and a GF Value™ of CHF90.02. The stock has 6 warning signs investors should review.

Gerresheimer AG's other long-term liabilities for the quarter that ended in Nov. 2025 was CHF308 Mil.

Gerresheimer AG's quarterly other long-term liabilities declined from May. 2025 (CHF339 Mil) to Aug. 2025 (CHF328 Mil) and declined from Aug. 2025 (CHF328 Mil) to Nov. 2025 (CHF308 Mil).

Gerresheimer AG's annual other long-term liabilities increased from Nov. 2023 (CHF230 Mil) to Nov. 2024 (CHF244 Mil) and increased from Nov. 2024 (CHF244 Mil) to Nov. 2025 (CHF308 Mil).

Gerresheimer AG Other Long-Term Liabilities Related Terms

Gerresheimer AG Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Gerresheimer AG's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG Other Long-Term Liabilities Chart

Gerresheimer AG Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 153.80 189.88 229.53 243.69 307.70

Gerresheimer AG Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 243.69 351.68 339.00 328.35 307.70
XSWX:GXI
68GF Score
Gerresheimer AG XSWX:GXI
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gerresheimer AG Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of CHF308 Mil mean?
Gerresheimer AG (XSWX:GXI) has a Other Long-Term Liabilities of CHF308 Mil as of Nov. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gerresheimer AG and its competitors.
Is Gerresheimer AG's Other Long-Term Liabilities too high?
Gerresheimer AG's current Other Long-Term Liabilities is CHF308 Mil. Overall, Gerresheimer AG has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Other Long-Term Liabilities compare to ISRG and BDX?
Gerresheimer AG's Other Long-Term Liabilities of CHF308 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Devices & Instruments company?
A good Other Long-Term Liabilities depends on the Medical Devices & Instruments industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gerresheimer AG and its competitors. Gerresheimer AG's current Other Long-Term Liabilities is CHF308 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Gerresheimer AG (XSWX:GXI) has a current Other Long-Term Liabilities of CHF308 Mil. The stock's GF Value™ is CHF90.02, compared to a current price of CHF25.84 — trading 71.3% below its estimated fair value. The current Other Long-Term Liabilities is CHF308 Mil. Gerresheimer AG's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Gerresheimer AG (XSWX:GXI), the current Other Long-Term Liabilities is CHF308 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gerresheimer AG (XSWX:GXI) Overvalued in 2026?

Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued. The current stock price of CHF25.84 is trading 71.3% below its estimated GF Value™ of CHF90.02.

Key valuation signals for XSWX:GXI:

  • Other Long-Term Liabilities: CHF308 Mil
  • GF Value™: CHF90.02 vs. price of CHF25.84 (71.3% below fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the XSWX:GXI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gerresheimer AG Business Description

Address Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
68GF Score

Get the complete analysis for XSWX:GXI

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF25.84
Price
CHF90.02
GF Value